Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gynecology

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 38 articles: HTML format

Single Articles

April 2024
1. KAUR P, Shankar E, Gupta S
   EZH2-mediated development of therapeutic resistance in cancer.
   Cancer Lett. 2024;586:216706.
   PubMed     Abstract available
   
   
   March 2024
2. PONGRATANAKUL P, Bremmer F, Pauls S, Poschmann G, et al
   Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers.
   Cancer Lett. 2024;585:216673.
   PubMed     Abstract available
   
   
   
3. CAO C, Xu Q, Zhu Z, Xu M, et al
   Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
   Cancer Lett. 2024 Mar 10:216809. doi: 10.1016/j.canlet.2024.216809.
   PubMed     Abstract available
   
   
   February 2024
4. LIU J, Liu C, Ma Y, Pan X, et al
   STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs).
   Cancer Lett. 2024 Feb 17:216700. doi: 10.1016/j.canlet.2024.216700.
   PubMed     Abstract available
   
   
   January 2024
5. AO K, Yin M, Lyu X, Xiao Y, et al
   METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
   Cancer Lett. 2024 Jan 20:216658. doi: 10.1016/j.canlet.2024.216658.
   PubMed     Abstract available
   
   
   
6. MEI X, Xiong J, Liu J, Huang A, et al
   DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
   Cancer Lett. 2024 Jan 9:216609. doi: 10.1016/j.canlet.2024.216609.
   PubMed     Abstract available
   
   
   December 2023
7. LIN CL, Ying TH, Yang SF, Lin CL, et al
   Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation.
   Cancer Lett. 2023 Dec 18:216584. doi: 10.1016/j.canlet.2023.216584.
   PubMed     Abstract available
   
   
   November 2023
8. NAMKAEW J, Zhang J, Yamakawa N, Hamada Y, et al
   Repositioning of mifepristone as an integrated stress response activator to potentiate cisplatin efficacy in non-small cell lung cancer.
   Cancer Lett. 2023 Nov 28:216509. doi: 10.1016/j.canlet.2023.216509.
   PubMed     Abstract available
   
   
   
9. GARG V, Kumar L
   Metronomic chemotherapy in ovarian cancer.
   Cancer Lett. 2023 Nov 1:216469. doi: 10.1016/j.canlet.2023.216469.
   PubMed     Abstract available
   
   
   October 2023
10. CHEN L, Zheng X, Liu W, Sun Y, et al
    Compound AC1Q3QWB upregulates CDKN1A and SOX17 by interrupting the HOTAIR-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer.
    Cancer Lett. 2023 Oct 20:216445. doi: 10.1016/j.canlet.2023.216445.
    PubMed     Abstract available
    
    
    
11. DOGRA S, Elayapillai SP, Qu D, Pitts K, et al
    Targeting doublecortin-like kinase 1 reveals a novel strategy to circumvent chemoresistance and metastasis in ovarian cancer.
    Cancer Lett. 2023 Oct 12:216437. doi: 10.1016/j.canlet.2023.216437.
    PubMed     Abstract available
    
    
    September 2023
12. YUE S, Wang Q, Zhang J, Hu Q, et al
    Understanding cervical cancer at single-cell resolution.
    Cancer Lett. 2023 Sep 26:216408. doi: 10.1016/j.canlet.2023.216408.
    PubMed     Abstract available
    
    
    
13. VENKATA PP, Jayamohan S, He Y, Alejo S, et al
    Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
    Cancer Lett. 2023 Sep 13:216383. doi: 10.1016/j.canlet.2023.216383.
    PubMed     Abstract available
    
    
    August 2023
14. ZHANG X, Guo H, Chen J, Xu C, et al
    Highly proliferative and hypodifferentiated CAR-T cells targeting B7-H3 enhance antitumor activity against ovarian and triple-negative breast cancers.
    Cancer Lett. 2023 Aug 17:216355. doi: 10.1016/j.canlet.2023.216355.
    PubMed     Abstract available
    
    
    July 2023
15. BERTAGNIN C, Messa L, Pavan M, Celegato M, et al
    A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells.
    Cancer Lett. 2023 Jul 31:216331. doi: 10.1016/j.canlet.2023.216331.
    PubMed     Abstract available
    
    
    
16. POOREBRAHIM M, Quiros-Fernandez I, Marme F, Burdach SE, et al
    A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
    Cancer Lett. 2023;566:216242.
    PubMed     Abstract available
    
    
    
17. CHEN X, Zhou J, Li X, Wang X, et al
    Corrigendum to "Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype" [Cancer Lett. 435 (28 October 2018) 80-91].
    Cancer Lett. 2023 Jul 8:216292. doi: 10.1016/j.canlet.2023.216292.
    PubMed    
    
    
    May 2023
18. SHAO Y, Li H, Wu Y, Wang X, et al
    The feedback loop of AURKA/DDX5/TMEM147-AS1/let-7 drives lipophagy to induce cisplatin resistance in epithelial ovarian cancer.
    Cancer Lett. 2023;565:216241.
    PubMed     Abstract available
    
    
    April 2023
19. MOSKOVICH D, Alfandari A, Finkelshtein Y, Weisz A, et al
    Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
    Cancer Lett. 2023;563:216196.
    PubMed    
    
    
    January 2023
20. ZHANG Y, Qiu JG, Jia XY, Ke Y, et al
    METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance.
    Cancer Lett. 2023;553:215971.
    PubMed     Abstract available
    
    
    
21. JIANG W, Ouyang X, Ji Z, Shi W, et al
    The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
    Cancer Lett. 2023;556:216064.
    PubMed     Abstract available
    
    
    
22. HOLLIS RL
    Molecular characteristics and clinical behaviour of epithelial ovarian cancers.
    Cancer Lett. 2023;555:216057.
    PubMed     Abstract available
    
    
    September 2022
23. ZHANG YR, Zheng PS
    NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes.
    Cancer Lett. 2022 Sep 14:215917. doi: 10.1016/j.canlet.2022.215917.
    PubMed     Abstract available
    
    
    August 2022
24. XIANG T, Du L, Pham P, Zhu B, et al
    Corrigendum to "Nelfinavir, an HIV protease inhibitor, induces apoptosis and cell cycle arrest in human cervical cancer cells via the ROS-dependent mitochondrial pathway" [Cancer Letters 364 (2015) 79-88].
    Cancer Lett. 2022 Aug 25:215895. doi: 10.1016/j.canlet.2022.215895.
    PubMed    
    
    
    June 2022
25. RUSSO A, Zizhao Y, Heyrman GM, Cain BP, et al
    Versican secreted by the ovary links ovulation and migration in fallopian tube derived serous cancer.
    Cancer Lett. 2022 Jun 10:215779. doi: 10.1016/j.canlet.2022.215779.
    PubMed     Abstract available
    
    
    May 2022
26. WANG W, Jo H, Park S, Kim H, et al
    Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
    Cancer Lett. 2022 May 12:215735. doi: 10.1016/j.canlet.2022.215735.
    PubMed     Abstract available
    
    
    April 2022
27. ZHAO Z, Shuang T, Gao Y, Lu F, et al
    Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.
    Cancer Lett. 2022;530:45-58.
    PubMed     Abstract available
    
    
    January 2022
28. SOTO-GAMEZ A, Wang Y, Zhou X, Seras L, et al
    Enhanced extrinsic apoptosis of therapy-induced senescent cancer cells using a death receptor 5 (DR5) selective agonist.
    Cancer Lett. 2022;525:67-75.
    PubMed     Abstract available
    
    
    
29. DU S, Qian J, Tan S, Li W, et al
    Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.
    Cancer Lett. 2022;529:168-179.
    PubMed     Abstract available
    
    
    
30. HERNANDEZ I, Cohen M
    Linking cell-surface GRP78 to cancer: From basic research to clinical value of GRP78 antibodies.
    Cancer Lett. 2022;524:1-14.
    PubMed     Abstract available
    
    
    December 2021
31. ZHAN L, Zhang J, Zhang J, Liu X, et al
    LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer.
    Cancer Lett. 2021;529:37-52.
    PubMed     Abstract available
    
    
    
32. QIAO HY, Zhang Q, Wang JM, Jiang JY, et al
    TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
    Cancer Lett. 2021;529:85-99.
    PubMed     Abstract available
    
    
    
33. SALINAS-MONTALVO AM, Supramaniam A, McMillan NA, Idris A, et al
    RNA-based gene targeting therapies for human papillomavirus driven cancers.
    Cancer Lett. 2021;523:111-120.
    PubMed     Abstract available
    
    
    
34. LIU C, Huang Y, Qin T, You L, et al
    AZD5153 reverses palbociclib resistance in ovarian cancer by inhibiting cell cycle-related proteins and the MAPK/PI3K-AKT pathway.
    Cancer Lett. 2021 Dec 20. pii: S0304-3835(21)00638.
    PubMed     Abstract available
    
    
    November 2021
35. SUN D, Qin Z, Xu Y, Xiao Q, et al
    The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation.
    Cancer Lett. 2021 Nov 11. pii: S0304-3835(21)00569.
    PubMed     Abstract available
    
    
    
36. PIN F, Prideaux M, Huot JR, Essex AL, et al
    Non-bone metastatic cancers promote osteocyte-induced bone destruction.
    Cancer Lett. 2021;520:80-90.
    PubMed     Abstract available
    
    
    October 2021
37. ZHAO S, Huang L, Basu P, Domingo EJ, et al
    Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries.
    Cancer Lett. 2021;525:22-32.
    PubMed     Abstract available
    
    
    
38. VENKATA PP, Chen Y, Alejo S, He Y, et al
    KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
    Cancer Lett. 2021;524:219-231.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.